Ranbaxy Laboratories has settled the litigation concerning its participation in the Texas Medicaid Program. Under the settlement agreement, the pharma major will make payments to the State of Texas totaling $39.75 million in a series of tranches through August 2015. The company has settled the matter to avoid any further distraction and uncertainty of continued litigation with the state of Texas.
Real Time News & Trading Trends Keep Liking Epic Research Private Limited
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment